However, a recent meta-analysis comprising data on SATB1′s expression in a cohort of 2083 CRC patients revealed that patients with a high SATB1 expression tended to have a shorter OS, and confirmed that a high SATB1 level was associated with a poor degree of tumour differentiation and the presence of distant metastasis [104]. This evidence concerns the gene SATB1 and colorectal carcinoma.